Jefferies Cuts Price Target on Parexel (PRXL) to $67 Following Weak 1Q

October 27, 2016 9:33 AM EDT
Get Alerts PRXL Hot Sheet
Price: $62.69 +0.11%

Rating Summary:
    5 Buy, 13 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 20 | Down: 30 | New: 23
Trade PRXL Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Jefferies maintained a Hold rating on PAREXEL International (NASDAQ: PRXL), and cut the price target to $67.00 (from $72.50), following the company's 1Q earnings report. EPS fell 10c below consensus and guidance midpoint. PRXL's revenue shortfall accounted for ~4c. Updated guidance reduces revenue by $20M. The 1Q miss was $25M alone. Guidance does add the ExecuPharm acquisition, and suggests that addition offsets the organic weakness over the balance of FY17.

Analyst David Windley commented, "PRXL has fumbled 3 of the last 4 FY 1Qs and 6 of the last 10. PRXL has struggled with slow study starts and resulting slowing backlog conversions for a couple of years, and heightened cancellations for ~5 quarters. These trends make a quick recovery and the revised guidance look optimistic. We expect PRXL to decline ~6-8% on Thursday."

For an analyst ratings summary and ratings history on PAREXEL International click here. For more ratings news on PAREXEL International click here.

Shares of PAREXEL International closed at $64.81 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co, Earnings, Definitive Agreement

Add Your Comment